Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21527006 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.
Condition: Restless Legs Syndrome
Interventions: Drug: XP13512 (GSK1838262);   Other: placebo
2 Completed
Has Results
XP13512 vs. Placebo in Patients With Restless Legs Syndrome.
Condition: Restless Legs Syndrome
Interventions: Drug: XP13512 600MG;   Drug: XP13512 1200MG;   Drug: PLACEBO

Indicates status has not been verified in more than two years